Bristol Myers Squibb Acquires Radiopharma Company RayzeBio
Bristol Myers Squibb has added a premier radiopharmaceutical platform to its portfolio with the acquisition of RayzeBio, a radiopharmaceutical therapeutics
Read more
Pharma Stocks
Moderna’s ‘Spikevax’ COVID-19 Vaccine Gets Full FDA Approval
The U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read more
Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic
Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read more
Valneva Stock Price Drops 40% as UK cancels vaccine deal
Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
Read more
Covid Vaccine Shares Hit by US Administration Decision to Wave Patents
The announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious
Read more
Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization
Read more
Phico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy
Phico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics
Read more
Thermo Fisher to Acquire CRO giant PPD for $17.4 Billion in Cash
Thermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo
Read more
Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers
Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read more
Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma
Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Read more